Moderna
MRNA
#1250
Rank
HK$142.08 B
Marketcap
HK$358.09
Share price
-4.97%
Change (1 day)
73.33%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -HK$24.35 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$2.20 Billion. In 2025 the company made an earning of -HK$21.61 Billion, an increase over its 2024 earnings that were of -HK$28.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$24.35 Billion12.71%
2025 -HK$21.61 Billion-23.03%
2024 -HK$28.07 Billion-8.22%
2023 -HK$30.58 Billion-140.65%
2022 HK$75.22 B-27.81%
2021 HK$104.19 B-1911.15%
2020 -HK$5.76 Billion44.7%
2019 -HK$3.98 Billion28.63%
2018 -HK$3.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.47 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.62 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$103.00 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-HK$0.38 Billion-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.81 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$2.70 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA